Comparative Pharmacology
Head-to-head clinical analysis: ADIPEX P versus ADPHEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ADIPEX P versus ADPHEN.
ADIPEX-P vs ADPHEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Phentermine is a sympathomimetic amine that stimulates release of norepinephrine and to a lesser extent dopamine and serotonin from presynaptic nerve terminals in the hypothalamic feeding center, resulting in appetite suppression.
Adphen is a combination of phentermine hydrochloride and diethylpropion hydrochloride. Phentermine is a sympathomimetic amine that acts as an appetite suppressant by stimulating the hypothalamus to release norepinephrine, thereby reducing food intake. Diethylpropion also has sympathomimetic activity, though its exact mechanism is not fully understood.
Phentermine (ADIPEX-P) is typically dosed as 15–37.5 mg orally once daily, administered 2 hours after breakfast or before breakfast. The 37.5 mg tablet is taken once daily before breakfast or 1–2 hours after breakfast; some patients may require 15 mg or 30 mg (half of a 37.5 mg tablet) once daily. The extended-release formulation (ADIPEX-P) is not available; only immediate-release tablets are marketed. Duration of therapy should be limited to a few weeks (e.g., 4–12 weeks) due to potential for tolerance and abuse.
5 mg orally once daily, titrated to a maximum of 10 mg once daily as tolerated.
None Documented
None Documented
Terminal half-life approximately 20-25 hours. Clinical context: Steady-state reached within 4-5 days; dosing adjustments may be needed in renal impairment.
Terminal elimination half-life is 10-15 hours in adults with normal renal function; prolonged to 20-30 hours in severe renal impairment (CrCl <30 mL/min).
Primarily renal (70-90% unchanged); minor biliary/fecal (10-30% as metabolites). Urinary pH-dependent; acidic urine increases excretion.
Primarily renal (70-90% as unchanged drug) with minor biliary (10-15% as metabolites). Fecal elimination is negligible (<5%).
Category C
Category C
Anorexiant
Anorexiant